Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

10.3322/canjclin.45.1.8

Miller BA, Ries LAG, Hankey BF, et al., eds. SEER cancer statistics review: 1973-1990. Bethesda, Md.: National Cancer Institute, 1993. (NIH publication no. 93-2789.)

Neijt JP, 1987, J Clin Oncol, 5, 1157, 10.1200/JCO.1987.5.8.1157

Omura GA, 1989, J Clin Oncol, 7, 457, 10.1200/JCO.1989.7.4.457

Dedrick RL, 1978, Cancer Treat Rep, 62, 1

Howell SB, 1982, Ann Intern Med, 97, 845, 10.7326/0003-4819-97-6-845

10.1093/jnci/81.20.1552

Howell SB, 1987, J Clin Oncol, 5, 1607, 10.1200/JCO.1987.5.10.1607

Kirmani S, 1991, J Clin Oncol, 9, 649, 10.1200/JCO.1991.9.4.649

Cox DR, 1972, J R Stat Soc [B], 34, 187

Piccart MJ, 1985, Semin Oncol, 12, 90

10.1016/0305-7372(86)90007-1

Markman M. Intraperitoneal chemotherapy for gynecologic malignancies. In: Deppe G, ed. Chemotherapy of gynecologic cancer. 2nd ed. New York: Alan R. Liss, 1990:375-90.

Los G, 1989, Cancer Res, 49, 3380

10.1056/NEJM199601043340101